Beth Sandy, MSN, CRNP, FAPO, led a discussion on EGFR-mutated non-small cell lung cancer, focusing on targeted therapies for those with advanced, treatment-naïve disease.
Targeted Therapies for Locally Advanced or Metastatic EGFR-mutated NSCLC
Advertisement
Advertisement
Trending on Oncology Nursing News
1
How An Adaptive Weight-Loss Strategy Benefits Breast Cancer Survivors
2
Cancer Surgery Waiting Times Rising: What Oncology Nurses Need to Know
3
Advances in Lymphoma Care: Experts Breakdown CAR T-Cell Therapy, Bispecifics, and CLL Management
4
Active Surveillance Rates Rise for Prostate Cancer in Veterans Health System
5